Fig. 4: Adjusted mean change in tau PET SUVR from baseline to week 78. | Nature Aging

Fig. 4: Adjusted mean change in tau PET SUVR from baseline to week 78.

From: TANGO: a placebo-controlled randomized phase 2 study of efficacy and safety of the anti-tau monoclonal antibody gosuranemab in early Alzheimer’s disease

Fig. 4: Adjusted mean change in tau PET SUVR from baseline to week 78.

a–c, Adjusted mean change from baseline (±s.e.) in the tau PET SUVR in composite regions corresponding to Braak stages I–II (a), III–IV (b) and V–VI (c). Sample sizes are provided for each group at each time point and are the same for all panels. Analyses were two-sided at a 5% significance level. No adjustments were made for multiple comparisons.

Source data

Back to article page